Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab, Vertex Sign Strategic Agreement To Develop, Commercialize Povetacicept In Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region And Singapore

Jan 10 (Reuters) - Zai Lab Ltd  9688.HK :
    * ZAI LAB AND VERTEX ANNOUNCE STRATEGIC AGREEMENT TO DEVELOP
AND
COMMERCIALIZE POVETACICEPT IN MAINLAND CHINA, HONG KONG SAR,
MACAU SAR, TAIWAN REGION AND SINGAPORE
    * ZAI LAB LTD - VERTEX TO RECEIVE UPFRONT PAYMENT, MILESTONE
PAYMENTS, AND ROYALTIES
    * ZAI LAB LTD - TO HANDLE COMMERCIALIZATION ACTIVITIES FOR
POVETACICEPT

Source text:  urn:newsml:reuters.com:*:nBw9wZyS4a
Further company coverage:  9688.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zai Lab

See all news